General Information of Drug (ID: DMS9I6A)

Drug Name
AZD7687 Drug Info
Synonyms
AZD7687; 1166827-44-6; CHEMBL2178944; CHEMBL2178953; AZD-7687; AZD 7687; UNII-6QTJ9P2NYT; 6QTJ9P2NYT; SCHEMBL2252415; SCHEMBL5532381; SCHEMBL2252417; GTPL7827; SCHEMBL2255196; DTXSID60655297; YXFNPRHZMOGREC-SHTZXODSSA-N; 3466AH; ZINC43206395; BDBM50399684; BDBM50399710; AZD 7687;AZD-7687; ZINC101581684; AKOS030526281; CS-1026; NCGC00378858-01; HY-15497; KB-144428; W-5990; {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid; {trans-4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid
Indication
Disease Entry ICD 11 Status REF
Diabetic complication 5A2Y Phase 1 [1]
Obesity 5B81 Phase 1 [1]
Cross-matching ID
PubChem CID
42636350
CAS Number
CAS 1166827-44-6
TTD Drug ID
DMS9I6A

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hesperetin DMKER83 High blood cholesterol level 5C80.00 Approved [3]
LCQ908 DMFLJHQ Familial chylomicronemia syndrome 5C80 Phase 3 [4]
P-7435 DMNZQU5 Diabetic complication 5A2Y Phase 1 [5]
PMID25470667-Compound-Figure4-1A DMMVQW8 N. A. N. A. Patented [6]
Azole derivative 7 DMVUJGI N. A. N. A. Patented [6]
Carbamide derivative 3 DM4ISCQ N. A. N. A. Patented [6]
T863 DMX41ZF Discovery agent N.A. Patented [6]
Benzamide derivative 19 DM5YNTM N. A. N. A. Patented [6]
Lactam derivative 5 DMX5FYZ N. A. N. A. Patented [6]
Pyridine-carboximide derivative 2 DMHXWZB N. A. N. A. Patented [6]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Diacylglycerol acyltransferase 1 (DGAT1) TTF8P9I DGAT1_HUMAN Inhibitor [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7827).
2 Clinical pipeline report, company report or official report of AstraZeneca (2011).
3 In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens. Planta Med. 2004 Mar;70(3):258-60.
4 DGAT1 inhibitors as anti-obesity and anti-diabetic agents. Curr Opin Drug Discov Devel. 2010 Jul;13(4):489-96.
5 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033014)
6 Acyltransferase inhibitors: a patent review (2010-present).Expert Opin Ther Pat. 2015 Feb;25(2):145-58.